Á. Pető, D. Kósa, P. Fehér, Zoltán Jhelyi, Dávid Sinka, M. Vecsernyés, Z. Szilvássy, B. Juhász, Z. Csanádi, I. Bácskay
{"title":"Pharmacological Overview of the Drug Candidate BGP-15","authors":"Á. Pető, D. Kósa, P. Fehér, Zoltán Jhelyi, Dávid Sinka, M. Vecsernyés, Z. Szilvássy, B. Juhász, Z. Csanádi, I. Bácskay","doi":"10.33892/aph.2021.91.298-299","DOIUrl":null,"url":null,"abstract":"BGP-15 is a drug candidate that was originally developed against insulin resistance by Hungarian researchers. This compound was discovered while investigating heat shock proteins, which are essentials in the functioning of the immune system [1]. BGP-15 is a versatile compound, many research groups pay outstanding attention to the molecule and investigate its effects all around the world. It has been reported to be safe and well tolerated, it entered into clinical phase II [2]. In the followings we summarize BGP-15’s effects to increase the knowledge about the molecule.","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta pharmaceutica Hungarica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33892/aph.2021.91.298-299","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
BGP-15 is a drug candidate that was originally developed against insulin resistance by Hungarian researchers. This compound was discovered while investigating heat shock proteins, which are essentials in the functioning of the immune system [1]. BGP-15 is a versatile compound, many research groups pay outstanding attention to the molecule and investigate its effects all around the world. It has been reported to be safe and well tolerated, it entered into clinical phase II [2]. In the followings we summarize BGP-15’s effects to increase the knowledge about the molecule.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
